SonoScape Medical Corp. (SHE:300633)
China · Delayed Price · Currency is CNY 26.87
-0.76 (-2.75%)
Apr 24, 2026, 3:04 PM CST
SonoScape Medical Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Jan '24 Jan 1, 2024 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Net Income | 197.28 | 142.4 | 454.44 | 369.81 | 247.24 |
Depreciation & Amortization | 99.02 | 85.76 | 66.03 | 53.37 | 53.65 |
Other Amortization | 11.23 | 5.8 | 2.95 | 4.15 | 4.17 |
Loss (Gain) From Sale of Assets | -0.03 | -0.05 | -0.02 | 0.74 | 0.19 |
Asset Writedown & Restructuring Costs | 1.21 | 57.02 | 16.23 | 0.59 | 37.34 |
Loss (Gain) From Sale of Investments | -2.36 | -4.16 | 11.28 | -8.21 | -15.03 |
Provision & Write-off of Bad Debts | 12.25 | 5.29 | 14.34 | 19.91 | 10.28 |
Other Operating Activities | 42.9 | 64.33 | 37.67 | 30.63 | 75.85 |
Change in Accounts Receivable | -72.76 | -45.53 | -71.01 | -6.35 | 0.46 |
Change in Inventory | -286 | -294.87 | -71.87 | -114.6 | -191.75 |
Change in Accounts Payable | -13.35 | 318.33 | -10.26 | 74.42 | 90.09 |
Change in Other Net Operating Assets | 3.11 | -5.91 | 40.92 | 52.43 | - |
Operating Cash Flow | -48.16 | 306.66 | 489.47 | 473.26 | 302.99 |
Operating Cash Flow Growth | - | -37.35% | 3.43% | 56.19% | 11.75% |
Capital Expenditures | -142.24 | -206.86 | -176.99 | -190.32 | -152.25 |
Sale of Property, Plant & Equipment | 0.13 | 0.19 | 0.3 | 0.53 | 0.17 |
Cash Acquisitions | - | - | 1.62 | - | - |
Investment in Securities | -72.1 | -384.9 | 370.5 | -279.12 | 208.88 |
Other Investing Activities | 5.75 | 0.43 | -9.25 | 34.86 | 14.73 |
Investing Cash Flow | -208.46 | -591.14 | 186.17 | -434.06 | 71.53 |
Short-Term Debt Issued | - | - | - | 222.15 | - |
Long-Term Debt Issued | 230.68 | 412.07 | 73.63 | - | 28.65 |
Total Debt Issued | 230.68 | 412.07 | 73.63 | 222.15 | 28.65 |
Short-Term Debt Repaid | - | - | - | -116.35 | - |
Long-Term Debt Repaid | -281.82 | -156.86 | -249.49 | -18.89 | -405.11 |
Total Debt Repaid | -281.82 | -156.86 | -249.49 | -135.24 | -405.11 |
Net Debt Issued (Repaid) | -51.15 | 255.21 | -175.86 | 86.91 | -376.46 |
Issuance of Common Stock | 7.97 | 31.4 | 43.05 | - | 772.11 |
Repurchase of Common Stock | - | -60.04 | -59.99 | -25.37 | -30.61 |
Common Dividends Paid | -47.23 | -144.34 | -82.72 | -57.76 | -5.54 |
Other Financing Activities | - | - | - | - | -2.18 |
Financing Cash Flow | -90.41 | 82.24 | -275.52 | 3.78 | 357.33 |
Foreign Exchange Rate Adjustments | 2.89 | -0.43 | 2.96 | 11.4 | -8.34 |
Net Cash Flow | -344.14 | -202.67 | 403.08 | 54.38 | 723.51 |
Free Cash Flow | -190.4 | 99.8 | 312.48 | 282.93 | 150.74 |
Free Cash Flow Growth | - | -68.06% | 10.44% | 87.69% | 30.13% |
Free Cash Flow Margin | -8.25% | 4.96% | 14.74% | 16.05% | 10.44% |
Free Cash Flow Per Share | -0.44 | 0.23 | 0.72 | 0.66 | 0.38 |
Cash Income Tax Paid | -37.52 | -30.64 | 20.5 | 2.74 | 8.18 |
Levered Free Cash Flow | -177.48 | 47.84 | 146.65 | 121.03 | 1.15 |
Unlevered Free Cash Flow | -174.88 | 52.02 | 149.81 | 123.35 | 4.62 |
Change in Working Capital | -409.66 | -49.73 | -113.45 | 2.26 | -110.7 |
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.